Loading…

Anethole Exerts Antimetatstaic Activity via Inhibition of Matrix Metalloproteinase 2/9 and AKT/Mitogen-Activated Kinase/Nuclear Factor Kappa B Signaling Pathways

Anethole is known to possess anti-inflammatory and anti-tumor activities and to be a main constituent of fennel, anise, and camphor. In the present study, we evaluated anti-metastatic and apoptotic effects of anethole on highly-metastatic HT-1080 human fibrosarcoma tumor cells. Despite weak cytotoxi...

Full description

Saved in:
Bibliographic Details
Published in:Biological & Pharmaceutical Bulletin 2011/01/01, Vol.34(1), pp.41-46
Main Authors: Choo, Eun Jeong, Rhee, Yun-Hee, Jeong, Soo-Jin, Lee, Hyo-Jung, Kim, Hyun Seok, Ko, Hyun Suk, Kim, Ji-Hyun, Kwon, Tae-Rin, Jung, Ji Hoon, Kim, Jin Hyoung, Lee, Hyo-Jeong, Lee, Eun-Ok, Kim, Dae Keun, Chen, Chang-Yan, Kim, Sung-Hoon
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c617t-eaa1ce4f1fa00b81708225591575f7dd7be2b18df3ff5fd2d50842f0c6108653
cites cdi_FETCH-LOGICAL-c617t-eaa1ce4f1fa00b81708225591575f7dd7be2b18df3ff5fd2d50842f0c6108653
container_end_page 46
container_issue 1
container_start_page 41
container_title Biological & Pharmaceutical Bulletin
container_volume 34
creator Choo, Eun Jeong
Rhee, Yun-Hee
Jeong, Soo-Jin
Lee, Hyo-Jung
Kim, Hyun Seok
Ko, Hyun Suk
Kim, Ji-Hyun
Kwon, Tae-Rin
Jung, Ji Hoon
Kim, Jin Hyoung
Lee, Hyo-Jeong
Lee, Eun-Ok
Kim, Dae Keun
Chen, Chang-Yan
Kim, Sung-Hoon
description Anethole is known to possess anti-inflammatory and anti-tumor activities and to be a main constituent of fennel, anise, and camphor. In the present study, we evaluated anti-metastatic and apoptotic effects of anethole on highly-metastatic HT-1080 human fibrosarcoma tumor cells. Despite weak cytotoxicity against HT-1080 cells, anethole inhibited the adhesion to Matrigel and invasion of HT-1080 cells in a dose-dependent manner. Anethole was also able to down-regulate the expression of matrix metalloproteinase (MMP)-2 and -9 and up-regulate the gene expression of tissue inhibitor of metalloproteinase (TIMP)-1. The similar inhibitory effect of anethole on MMP-2 and -9 activities was confirmed by zymography assay. Furthermore, anethole significantly decreased mRNA expression of urokinase plasminogen activator (uPA), but not uPA receptor (uPAR). In addition, anethole suppressed the phosphorylation of AKT, extracellular signal-regulated kinase (ERK), p38 and nuclear transcription factor kappa B (NF-κB) in HT-1080 cells. Taken together, our findings indicate that anethole is a potent anti-metastatic drug that functions through inhibiting MMP-2/9 and AKT/mitogen-activated protein kinase (MAPK)/NF-κB signal transducers.
doi_str_mv 10.1248/bpb.34.41
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_822903985</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3121491701</sourcerecordid><originalsourceid>FETCH-LOGICAL-c617t-eaa1ce4f1fa00b81708225591575f7dd7be2b18df3ff5fd2d50842f0c6108653</originalsourceid><addsrcrecordid>eNpdkc9uEzEQxi0EomngwAsgSxwQh038N7t7QQpVW6o0gETu1qzXmzja2KntlOZx-qY4TVMkZHnGkn_zzdgfQh8oGVEmqnGzbUZcjAR9hQaUi7KQjMrXaEBqWhUTKqszdB7jmhBSEsbfojNG85JUDtDj1Jm08r3Blw8mpIinLtmNSZBiAqvxVCd7b9Me31vAN25lG5usd9h3eA4p2Ac8z3Df-23wyVgH0WA2rjG4Fk9ni_HcJr80rnjSgWRaPHuCxj92ujcQ8BXo5AOewXYL-Bv-bZcOeuuW-Bek1R_Yx3foTQd9NO-f8xAtri4XF9-L25_XNxfT20JPaJkKA0C1ER3tgJCmoiWpGJOyprKUXdm2ZWNYQ6u2410nu5a1klSCdSRXk2oi-RB9Psrmh9ztTExqY6M2fQ_O-F1UWa0mvK4O5Kf_yLXfhTx1VFSImpcVy3GIvhwpHXyMwXRqG-wGwl5Rog6uqeya4kIJmtmPz4q7ZmPaF_JkUwauj0C-tRp67_IXmX99dSwb63uvGKFUEcIFOaQyb3E4iAnldZY6jPX1qLTO_i7NSysIyWZDTkPRY8jFpwu9gqCM438B9NXAhg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449378249</pqid></control><display><type>article</type><title>Anethole Exerts Antimetatstaic Activity via Inhibition of Matrix Metalloproteinase 2/9 and AKT/Mitogen-Activated Kinase/Nuclear Factor Kappa B Signaling Pathways</title><source>Free Full-Text Journals in Chemistry</source><creator>Choo, Eun Jeong ; Rhee, Yun-Hee ; Jeong, Soo-Jin ; Lee, Hyo-Jung ; Kim, Hyun Seok ; Ko, Hyun Suk ; Kim, Ji-Hyun ; Kwon, Tae-Rin ; Jung, Ji Hoon ; Kim, Jin Hyoung ; Lee, Hyo-Jeong ; Lee, Eun-Ok ; Kim, Dae Keun ; Chen, Chang-Yan ; Kim, Sung-Hoon</creator><creatorcontrib>Choo, Eun Jeong ; Rhee, Yun-Hee ; Jeong, Soo-Jin ; Lee, Hyo-Jung ; Kim, Hyun Seok ; Ko, Hyun Suk ; Kim, Ji-Hyun ; Kwon, Tae-Rin ; Jung, Ji Hoon ; Kim, Jin Hyoung ; Lee, Hyo-Jeong ; Lee, Eun-Ok ; Kim, Dae Keun ; Chen, Chang-Yan ; Kim, Sung-Hoon ; bYonsei University School of Medicine ; Harvard Medical School ; aCollege of Oriental Medicine ; Woosuk University ; dBeth Israel Deaconess Medical Center ; cCollege of Pharmacy ; Kyung Hee University</creatorcontrib><description>Anethole is known to possess anti-inflammatory and anti-tumor activities and to be a main constituent of fennel, anise, and camphor. In the present study, we evaluated anti-metastatic and apoptotic effects of anethole on highly-metastatic HT-1080 human fibrosarcoma tumor cells. Despite weak cytotoxicity against HT-1080 cells, anethole inhibited the adhesion to Matrigel and invasion of HT-1080 cells in a dose-dependent manner. Anethole was also able to down-regulate the expression of matrix metalloproteinase (MMP)-2 and -9 and up-regulate the gene expression of tissue inhibitor of metalloproteinase (TIMP)-1. The similar inhibitory effect of anethole on MMP-2 and -9 activities was confirmed by zymography assay. Furthermore, anethole significantly decreased mRNA expression of urokinase plasminogen activator (uPA), but not uPA receptor (uPAR). In addition, anethole suppressed the phosphorylation of AKT, extracellular signal-regulated kinase (ERK), p38 and nuclear transcription factor kappa B (NF-κB) in HT-1080 cells. Taken together, our findings indicate that anethole is a potent anti-metastatic drug that functions through inhibiting MMP-2/9 and AKT/mitogen-activated protein kinase (MAPK)/NF-κB signal transducers.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.34.41</identifier><identifier>PMID: 21212515</identifier><language>eng</language><publisher>Japan: The Pharmaceutical Society of Japan</publisher><subject>AKT ; anethole ; Animals ; Anisoles - chemistry ; Anisoles - pharmacology ; antimetastasis ; Cell Line, Tumor ; Dose-Response Relationship, Drug ; Humans ; matrix metalloproteinase ; Matrix Metalloproteinase Inhibitors ; mitogen-activated kinase ; Mitogen-Activated Protein Kinase Kinases - antagonists &amp; inhibitors ; Molecular Structure ; Neoplasm Metastasis - prevention &amp; control ; NF-kappa B - antagonists &amp; inhibitors ; nuclear transcription factor kappa B ; Proto-Oncogene Proteins c-akt - antagonists &amp; inhibitors ; Signal Transduction</subject><ispartof>Biological and Pharmaceutical Bulletin, 2011/01/01, Vol.34(1), pp.41-46</ispartof><rights>2011 The Pharmaceutical Society of Japan</rights><rights>Copyright Japan Science and Technology Agency 2011</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c617t-eaa1ce4f1fa00b81708225591575f7dd7be2b18df3ff5fd2d50842f0c6108653</citedby><cites>FETCH-LOGICAL-c617t-eaa1ce4f1fa00b81708225591575f7dd7be2b18df3ff5fd2d50842f0c6108653</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4022,27922,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21212515$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Choo, Eun Jeong</creatorcontrib><creatorcontrib>Rhee, Yun-Hee</creatorcontrib><creatorcontrib>Jeong, Soo-Jin</creatorcontrib><creatorcontrib>Lee, Hyo-Jung</creatorcontrib><creatorcontrib>Kim, Hyun Seok</creatorcontrib><creatorcontrib>Ko, Hyun Suk</creatorcontrib><creatorcontrib>Kim, Ji-Hyun</creatorcontrib><creatorcontrib>Kwon, Tae-Rin</creatorcontrib><creatorcontrib>Jung, Ji Hoon</creatorcontrib><creatorcontrib>Kim, Jin Hyoung</creatorcontrib><creatorcontrib>Lee, Hyo-Jeong</creatorcontrib><creatorcontrib>Lee, Eun-Ok</creatorcontrib><creatorcontrib>Kim, Dae Keun</creatorcontrib><creatorcontrib>Chen, Chang-Yan</creatorcontrib><creatorcontrib>Kim, Sung-Hoon</creatorcontrib><creatorcontrib>bYonsei University School of Medicine</creatorcontrib><creatorcontrib>Harvard Medical School</creatorcontrib><creatorcontrib>aCollege of Oriental Medicine</creatorcontrib><creatorcontrib>Woosuk University</creatorcontrib><creatorcontrib>dBeth Israel Deaconess Medical Center</creatorcontrib><creatorcontrib>cCollege of Pharmacy</creatorcontrib><creatorcontrib>Kyung Hee University</creatorcontrib><title>Anethole Exerts Antimetatstaic Activity via Inhibition of Matrix Metalloproteinase 2/9 and AKT/Mitogen-Activated Kinase/Nuclear Factor Kappa B Signaling Pathways</title><title>Biological &amp; Pharmaceutical Bulletin</title><addtitle>Biol Pharm Bull</addtitle><description>Anethole is known to possess anti-inflammatory and anti-tumor activities and to be a main constituent of fennel, anise, and camphor. In the present study, we evaluated anti-metastatic and apoptotic effects of anethole on highly-metastatic HT-1080 human fibrosarcoma tumor cells. Despite weak cytotoxicity against HT-1080 cells, anethole inhibited the adhesion to Matrigel and invasion of HT-1080 cells in a dose-dependent manner. Anethole was also able to down-regulate the expression of matrix metalloproteinase (MMP)-2 and -9 and up-regulate the gene expression of tissue inhibitor of metalloproteinase (TIMP)-1. The similar inhibitory effect of anethole on MMP-2 and -9 activities was confirmed by zymography assay. Furthermore, anethole significantly decreased mRNA expression of urokinase plasminogen activator (uPA), but not uPA receptor (uPAR). In addition, anethole suppressed the phosphorylation of AKT, extracellular signal-regulated kinase (ERK), p38 and nuclear transcription factor kappa B (NF-κB) in HT-1080 cells. Taken together, our findings indicate that anethole is a potent anti-metastatic drug that functions through inhibiting MMP-2/9 and AKT/mitogen-activated protein kinase (MAPK)/NF-κB signal transducers.</description><subject>AKT</subject><subject>anethole</subject><subject>Animals</subject><subject>Anisoles - chemistry</subject><subject>Anisoles - pharmacology</subject><subject>antimetastasis</subject><subject>Cell Line, Tumor</subject><subject>Dose-Response Relationship, Drug</subject><subject>Humans</subject><subject>matrix metalloproteinase</subject><subject>Matrix Metalloproteinase Inhibitors</subject><subject>mitogen-activated kinase</subject><subject>Mitogen-Activated Protein Kinase Kinases - antagonists &amp; inhibitors</subject><subject>Molecular Structure</subject><subject>Neoplasm Metastasis - prevention &amp; control</subject><subject>NF-kappa B - antagonists &amp; inhibitors</subject><subject>nuclear transcription factor kappa B</subject><subject>Proto-Oncogene Proteins c-akt - antagonists &amp; inhibitors</subject><subject>Signal Transduction</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNpdkc9uEzEQxi0EomngwAsgSxwQh038N7t7QQpVW6o0gETu1qzXmzja2KntlOZx-qY4TVMkZHnGkn_zzdgfQh8oGVEmqnGzbUZcjAR9hQaUi7KQjMrXaEBqWhUTKqszdB7jmhBSEsbfojNG85JUDtDj1Jm08r3Blw8mpIinLtmNSZBiAqvxVCd7b9Me31vAN25lG5usd9h3eA4p2Ac8z3Df-23wyVgH0WA2rjG4Fk9ni_HcJr80rnjSgWRaPHuCxj92ujcQ8BXo5AOewXYL-Bv-bZcOeuuW-Bek1R_Yx3foTQd9NO-f8xAtri4XF9-L25_XNxfT20JPaJkKA0C1ER3tgJCmoiWpGJOyprKUXdm2ZWNYQ6u2410nu5a1klSCdSRXk2oi-RB9Psrmh9ztTExqY6M2fQ_O-F1UWa0mvK4O5Kf_yLXfhTx1VFSImpcVy3GIvhwpHXyMwXRqG-wGwl5Rog6uqeya4kIJmtmPz4q7ZmPaF_JkUwauj0C-tRp67_IXmX99dSwb63uvGKFUEcIFOaQyb3E4iAnldZY6jPX1qLTO_i7NSysIyWZDTkPRY8jFpwu9gqCM438B9NXAhg</recordid><startdate>20110101</startdate><enddate>20110101</enddate><creator>Choo, Eun Jeong</creator><creator>Rhee, Yun-Hee</creator><creator>Jeong, Soo-Jin</creator><creator>Lee, Hyo-Jung</creator><creator>Kim, Hyun Seok</creator><creator>Ko, Hyun Suk</creator><creator>Kim, Ji-Hyun</creator><creator>Kwon, Tae-Rin</creator><creator>Jung, Ji Hoon</creator><creator>Kim, Jin Hyoung</creator><creator>Lee, Hyo-Jeong</creator><creator>Lee, Eun-Ok</creator><creator>Kim, Dae Keun</creator><creator>Chen, Chang-Yan</creator><creator>Kim, Sung-Hoon</creator><general>The Pharmaceutical Society of Japan</general><general>Pharmaceutical Society of Japan</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20110101</creationdate><title>Anethole Exerts Antimetatstaic Activity via Inhibition of Matrix Metalloproteinase 2/9 and AKT/Mitogen-Activated Kinase/Nuclear Factor Kappa B Signaling Pathways</title><author>Choo, Eun Jeong ; Rhee, Yun-Hee ; Jeong, Soo-Jin ; Lee, Hyo-Jung ; Kim, Hyun Seok ; Ko, Hyun Suk ; Kim, Ji-Hyun ; Kwon, Tae-Rin ; Jung, Ji Hoon ; Kim, Jin Hyoung ; Lee, Hyo-Jeong ; Lee, Eun-Ok ; Kim, Dae Keun ; Chen, Chang-Yan ; Kim, Sung-Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c617t-eaa1ce4f1fa00b81708225591575f7dd7be2b18df3ff5fd2d50842f0c6108653</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>AKT</topic><topic>anethole</topic><topic>Animals</topic><topic>Anisoles - chemistry</topic><topic>Anisoles - pharmacology</topic><topic>antimetastasis</topic><topic>Cell Line, Tumor</topic><topic>Dose-Response Relationship, Drug</topic><topic>Humans</topic><topic>matrix metalloproteinase</topic><topic>Matrix Metalloproteinase Inhibitors</topic><topic>mitogen-activated kinase</topic><topic>Mitogen-Activated Protein Kinase Kinases - antagonists &amp; inhibitors</topic><topic>Molecular Structure</topic><topic>Neoplasm Metastasis - prevention &amp; control</topic><topic>NF-kappa B - antagonists &amp; inhibitors</topic><topic>nuclear transcription factor kappa B</topic><topic>Proto-Oncogene Proteins c-akt - antagonists &amp; inhibitors</topic><topic>Signal Transduction</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Choo, Eun Jeong</creatorcontrib><creatorcontrib>Rhee, Yun-Hee</creatorcontrib><creatorcontrib>Jeong, Soo-Jin</creatorcontrib><creatorcontrib>Lee, Hyo-Jung</creatorcontrib><creatorcontrib>Kim, Hyun Seok</creatorcontrib><creatorcontrib>Ko, Hyun Suk</creatorcontrib><creatorcontrib>Kim, Ji-Hyun</creatorcontrib><creatorcontrib>Kwon, Tae-Rin</creatorcontrib><creatorcontrib>Jung, Ji Hoon</creatorcontrib><creatorcontrib>Kim, Jin Hyoung</creatorcontrib><creatorcontrib>Lee, Hyo-Jeong</creatorcontrib><creatorcontrib>Lee, Eun-Ok</creatorcontrib><creatorcontrib>Kim, Dae Keun</creatorcontrib><creatorcontrib>Chen, Chang-Yan</creatorcontrib><creatorcontrib>Kim, Sung-Hoon</creatorcontrib><creatorcontrib>bYonsei University School of Medicine</creatorcontrib><creatorcontrib>Harvard Medical School</creatorcontrib><creatorcontrib>aCollege of Oriental Medicine</creatorcontrib><creatorcontrib>Woosuk University</creatorcontrib><creatorcontrib>dBeth Israel Deaconess Medical Center</creatorcontrib><creatorcontrib>cCollege of Pharmacy</creatorcontrib><creatorcontrib>Kyung Hee University</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biological &amp; Pharmaceutical Bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Choo, Eun Jeong</au><au>Rhee, Yun-Hee</au><au>Jeong, Soo-Jin</au><au>Lee, Hyo-Jung</au><au>Kim, Hyun Seok</au><au>Ko, Hyun Suk</au><au>Kim, Ji-Hyun</au><au>Kwon, Tae-Rin</au><au>Jung, Ji Hoon</au><au>Kim, Jin Hyoung</au><au>Lee, Hyo-Jeong</au><au>Lee, Eun-Ok</au><au>Kim, Dae Keun</au><au>Chen, Chang-Yan</au><au>Kim, Sung-Hoon</au><aucorp>bYonsei University School of Medicine</aucorp><aucorp>Harvard Medical School</aucorp><aucorp>aCollege of Oriental Medicine</aucorp><aucorp>Woosuk University</aucorp><aucorp>dBeth Israel Deaconess Medical Center</aucorp><aucorp>cCollege of Pharmacy</aucorp><aucorp>Kyung Hee University</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anethole Exerts Antimetatstaic Activity via Inhibition of Matrix Metalloproteinase 2/9 and AKT/Mitogen-Activated Kinase/Nuclear Factor Kappa B Signaling Pathways</atitle><jtitle>Biological &amp; Pharmaceutical Bulletin</jtitle><addtitle>Biol Pharm Bull</addtitle><date>2011-01-01</date><risdate>2011</risdate><volume>34</volume><issue>1</issue><spage>41</spage><epage>46</epage><pages>41-46</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>Anethole is known to possess anti-inflammatory and anti-tumor activities and to be a main constituent of fennel, anise, and camphor. In the present study, we evaluated anti-metastatic and apoptotic effects of anethole on highly-metastatic HT-1080 human fibrosarcoma tumor cells. Despite weak cytotoxicity against HT-1080 cells, anethole inhibited the adhesion to Matrigel and invasion of HT-1080 cells in a dose-dependent manner. Anethole was also able to down-regulate the expression of matrix metalloproteinase (MMP)-2 and -9 and up-regulate the gene expression of tissue inhibitor of metalloproteinase (TIMP)-1. The similar inhibitory effect of anethole on MMP-2 and -9 activities was confirmed by zymography assay. Furthermore, anethole significantly decreased mRNA expression of urokinase plasminogen activator (uPA), but not uPA receptor (uPAR). In addition, anethole suppressed the phosphorylation of AKT, extracellular signal-regulated kinase (ERK), p38 and nuclear transcription factor kappa B (NF-κB) in HT-1080 cells. Taken together, our findings indicate that anethole is a potent anti-metastatic drug that functions through inhibiting MMP-2/9 and AKT/mitogen-activated protein kinase (MAPK)/NF-κB signal transducers.</abstract><cop>Japan</cop><pub>The Pharmaceutical Society of Japan</pub><pmid>21212515</pmid><doi>10.1248/bpb.34.41</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-6158
ispartof Biological and Pharmaceutical Bulletin, 2011/01/01, Vol.34(1), pp.41-46
issn 0918-6158
1347-5215
language eng
recordid cdi_proquest_miscellaneous_822903985
source Free Full-Text Journals in Chemistry
subjects AKT
anethole
Animals
Anisoles - chemistry
Anisoles - pharmacology
antimetastasis
Cell Line, Tumor
Dose-Response Relationship, Drug
Humans
matrix metalloproteinase
Matrix Metalloproteinase Inhibitors
mitogen-activated kinase
Mitogen-Activated Protein Kinase Kinases - antagonists & inhibitors
Molecular Structure
Neoplasm Metastasis - prevention & control
NF-kappa B - antagonists & inhibitors
nuclear transcription factor kappa B
Proto-Oncogene Proteins c-akt - antagonists & inhibitors
Signal Transduction
title Anethole Exerts Antimetatstaic Activity via Inhibition of Matrix Metalloproteinase 2/9 and AKT/Mitogen-Activated Kinase/Nuclear Factor Kappa B Signaling Pathways
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T02%3A32%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anethole%20Exerts%20Antimetatstaic%20Activity%20via%20Inhibition%20of%20Matrix%20Metalloproteinase%202/9%20and%20AKT/Mitogen-Activated%20Kinase/Nuclear%20Factor%20Kappa%20B%20Signaling%20Pathways&rft.jtitle=Biological%20&%20Pharmaceutical%20Bulletin&rft.au=Choo,%20Eun%20Jeong&rft.aucorp=bYonsei%20University%20School%20of%20Medicine&rft.date=2011-01-01&rft.volume=34&rft.issue=1&rft.spage=41&rft.epage=46&rft.pages=41-46&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.34.41&rft_dat=%3Cproquest_cross%3E3121491701%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c617t-eaa1ce4f1fa00b81708225591575f7dd7be2b18df3ff5fd2d50842f0c6108653%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1449378249&rft_id=info:pmid/21212515&rfr_iscdi=true